Article
Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects against Neurodegeneration in Experimental Multiple Sclerosis.
The Journal of biological chemistry - 26 Feb 2016
Warne Justin, Pryce Gareth, Hill Julia M, Shi Xiao, Lennerås Felicia, Puentes Fabiola, Kip Maarten, Hilditch Laura, Walker Paul, Simone Michela I, Chan A W Edith, Towers Greg J, Coker Alun R, Duchen Michael R, Szabadkai Gyorgy, Baker David, Selwood David L
Abstract excerpt
The mitochondrial permeability transition pore is a recognized drug target for neurodegenerative conditions such as multiple sclerosis and for ischemia-reperfusion injury in the brain and heart. The peptidylprolyl isomerase, cyclophilin D (CypD, PPIF), is a positive regulator of the pore, and genetic down-regulation or knock-out improves outcomes in disease models. Current inhibitors of peptidylprolyl isomerases...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
